Juvenescence

Juvenescence is a biotech company that develops therapies and products to modify aging and help people live longer.

Business Model:

Revenue: $0

Employees: 0-0

Rankings

Detailed Juvenescence Information

Geographic Data

Juvenescence headquarters map

Address:

City:

State:

Zip:

Country:

Financial Info

Stage:

Raised Last:

$57M

Raised Total:

$219M

Metrics

595,314Website Global Rank

73,895Website Monthly Traffic

Twitter Followers

Description

Juvenescence Limited is a British Virgin Islands-based holding company that invests in human aging and longevity. Juvenescence has raised $111M to build an ecosystem and pipeline of assets targeting aging, age-related disease, and regeneration. Juvenescence believes that recent scientific and medical advances will enable the development of therapeutics that meaningfully extend human healthspan and eventually lifespan. A meaningful increase in lifespan in the already aging world will have profound implications on all sectors of society, and in particular healthcare, education, insurance, and leisure. The company creates and partners with new companies with longevity-related therapeutics, by in-licensing compounds from academia and industry, or forming joint ventures with the foremost longevity scientists and leading research institutions. Their work is based on a novel scientific understanding of the underlying biological causes of aging, to create evidence-based therapeutics that can treat diseases of aging. Juvenescence&s;s goal is to extend both lifespan and healthspan, by developing therapeutics that slow aging and promote juvenescence.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
1/2023 Morphoceuticals Seed Round 0
8/2018 Napa Therapeutics Venture Round 3M
9/2018 AgeX Therapeutics Private Equity Round 43.2M
3/2022 MDI Therapeutics Series A 9M
5/2019 Souvien Therapeutics Venture Round 3.5M
7/2018 FoxBio Venture Round 10M
5/2018 LyGenesis Series A 3M
10/2019 LyGenesis Debt Financing 4M
12/2020 LyGenesis Convertible Note 11M
6/2018 AgeX Therapeutics Private Equity Round 5M
3/2019 BYOMass Venture Round 1.5M
2/2019 BHB Therapeutics Venture Round 3M
6/2018 Insilico Medicine Series A 6M
3/2022 MDI Therapeutics Series A 0
12/2020 LyGenesis Convertible Note 0
10/2019 LyGenesis Debt Financing 0
5/2019 Souvien Therapeutics Venture Round 0
3/2019 BYOMass Venture Round 0
2/2019 BHB Therapeutics Venture Round 0
9/2018 AgeX Therapeutics Private Equity Round 0
8/2018 Napa Therapeutics Venture Round 0
7/2018 FoxBio Venture Round 0
6/2018 Insilico Medicine Series A 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research